Alexza Pharmaceuticals (ALXA) Tops Q2 EPS by 4c
Alexza Pharmaceuticals (Nasdaq: ALXA) reports a Q2 loss of $0.43, 4 cents better than the analyst estimate of ($0.47). No revenues were reported for the quarter.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
